Lars Fruergaard Jørgensen | President & Chief Executive Officer |
Karsten Munk Knudsen | Chief Financial Officer |
Camilla Sylvest | Executive Vice President, Head of Commercial Strategy & Corporate Affair |
Doug Langa | Executive Vice President & Head of North America Operations |
Martin Holst Lange | Executive Vice President & Head of Development |
Emmanuel Papadakis | Deutsche Bank |
Matthew Weston | Credit Suisse |
Wimal Kapadia | Bernstein |
Steve Scala | Cowen |
Peter Verdult | Citi |
Martin Parkhøi | Danske Bank |
Carsten Madsen | SEB |
Michael Novod | Nordea Markets |
Sachin Jain | Bank of America |
Seamus Fernandez | Guggenheim Securities |
Keyur Parekh | Goldman Sachs |
Thank you very much and welcome to this Novo Nordisk Earnings Call for the First Six Months of 2021 and the outlook for the year. I'm Lars Fruergaard Jørgensen, the CEO of Novo Nordisk. I'd like to start by thanking you for your scheduling flexibility today as we decided to advance this earnings call as a consequence of our earlier than anticipated release of our results following an upgrade of both sales and operating profit. With me I have our Chief Financial Officer, Karsten Munk Knudsen; Executive Vice President and Head of Commercial Strategy and Corporate Affair, Camilla Sylvest; Executive Vice President and Head of North America Operations, Doug Langa; and finally Executive Vice President and Head of Development, Martin Holst Lange. All presenters will be available for the Q&A session.